{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:57:23Z","timestamp":1784858243966,"version":"3.55.0"},"reference-count":102,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,5,3]]},"abstract":"<jats:p>Wang et al. analyze Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment accuracy as screening tests for detecting dementia associated with Alzheimer\u2019s disease (AD). Such tests are at the center of controversy regarding recognition and treatment of AD. The continued widespread use of tools such as MMSE (1975) underscores the failure of advancing cognitive screening and assessment, which has hampered the development and evaluation of AD treatments. It is time to employ readily available, efficient computerized measures for population\/mass screening, clinical assessment of dementia progression, and accurate determination of approaches for prevention and treatment of AD and related conditions.<\/jats:p>","DOI":"10.3233\/jad-220211","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T13:25:47Z","timestamp":1649769947000},"page":"305-315","source":"Crossref","is-referenced-by-count":22,"title":["Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement"],"prefix":"10.1177","volume":"87","author":[{"given":"J. Wesson","family":"Ashford","sequence":"first","affiliation":[{"name":"War Related Illness and Injury Study Center, VA Palo Alto HCS, Palo Alto, CA, USA"},{"name":"Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA"},{"name":"Medical, Scientific, Memory Screening Advisory Board, Alzheimer\u2019s Foundation of American (AFA), New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Medical, Scientific, Memory Screening Advisory Board, Alzheimer\u2019s Foundation of American (AFA), New York, USA"},{"name":"Departments of Neurology, Psychiatry, Neurosurgery, Psychology, Behavioral Science; Sanders-Brown Center on Aging, Spinal Cord & Brain Injury Research Center, University of Kentucky, Sanders-Brown Center on Aging, Lexington, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Bergeron","sequence":"additional","affiliation":[{"name":"SIVOTEC Analytics, Boca Raton, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Bayley","sequence":"additional","affiliation":[{"name":"War Related Illness and Injury Study Center, VA Palo Alto HCS, Palo Alto, CA, USA"},{"name":"Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA"},{"name":"Medical, Scientific, Memory Screening Advisory Board, Alzheimer\u2019s Foundation of American (AFA), New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James O.","family":"Clifford","sequence":"additional","affiliation":[{"name":"College of San Mateo, San Mateo, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Xu","sequence":"additional","affiliation":[{"name":"Health Management Center, Department of Neurology, Renji Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China"},{"name":"Yunnan Provincial Clinical Research Center for Neurological Diseases, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbo","family":"Zhou","sequence":"additional","affiliation":[{"name":"Center for Alzheimer\u2019s Research, Washington Institute of Clinical Research, Vienna, VA, USA"},{"name":"Zhongze Therapeutics, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[{"name":"University of Illinois, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Buschke","sequence":"additional","affiliation":[{"name":"Medical, Scientific, Memory Screening Advisory Board, Alzheimer\u2019s Foundation of American (AFA), New York, USA"},{"name":"The Saul R. Korey Department of Neurology and Dominick P. Purpura Department of Neuroscience, Lena and Joseph Gluck Distinguished Scholar in Neurology, Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Dean","sequence":"additional","affiliation":[{"name":"Medical, Scientific, Memory Screening Advisory Board, Alzheimer\u2019s Foundation of American (AFA), New York, USA"},{"name":"Geriatric Division, Internal Medicine, Texas Tech Health Sciences Center, Amarillo, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanford I.","family":"Finkel","sequence":"additional","affiliation":[{"name":"Medical, Scientific, Memory Screening Advisory Board, Alzheimer\u2019s Foundation of American (AFA), New York, USA"},{"name":"University of Chicago Medical School, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Hyer","sequence":"additional","affiliation":[{"name":"Medical, Scientific, Memory Screening Advisory Board, Alzheimer\u2019s Foundation of American (AFA), New York, USA"},{"name":"Gateway Behavioral Health, Mercer University, School of Medicine, Savannah, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Perry","sequence":"additional","affiliation":[{"name":"Medical, Scientific, Memory Screening Advisory Board, Alzheimer\u2019s Foundation of American (AFA), New York, USA"},{"name":"Brain Health Consortium, Department Biology and Chemistry, University of Texas at San Antonio, San Antonio, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220211_ref1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jalz.2013.05.1768","article-title":"Leveraging global resources to end the Alzheimer\u2019s pandemic","volume":"9","author":"Carrillo","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220211_ref2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-200831","article-title":"COVID-19: Review of a 21st century pandemic from etiology to neuro-psychiatric implications","volume":"77","author":"Yamamoto","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref3","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Collaborators GBDDF","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.3233\/JAD-220211_ref4","first-page":"28","article-title":"Standard, routine cognitive screening: An idea whose time has come?","volume":"2","author":"Gilbert","year":"2019","journal-title":"CSA J"},{"key":"10.3233\/JAD-220211_ref5","first-page":"158","article-title":"Rationale for early diagnosis of mild cognitive impairment (MCI) supported by emerging digital technologies","volume":"7","author":"Sabbagh","year":"2020","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref6","first-page":"165","article-title":"Early detection of mild cognitive impairment (MCI) in primary care","volume":"7","author":"Sabbagh","year":"2020","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref7","first-page":"171","article-title":"Early detection of mild cognitive impairment (MCI) in an at-home setting","volume":"7","author":"Sabbagh","year":"2020","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref9","unstructured":"Bredesen DE (2017) The End of Alzheimer\u2019s: The First Program to Prevent and Reverse Cognitive Decline, Penguin Random House, New York."},{"key":"10.3233\/JAD-220211_ref10","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1162\/jocn_a_01164","article-title":"The effects of physical exercise and cognitive training on memory and neurotrophic factors","volume":"29","author":"Heisz","year":"2017","journal-title":"J Cogn Neurosci"},{"key":"10.3233\/JAD-220211_ref11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.3233\/JAD-220211_ref12","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12535"},{"key":"10.3233\/JAD-220211_ref13","doi-asserted-by":"crossref","first-page":"e922","DOI":"10.1212\/WNL.0000000000012388","article-title":"Cognitive activity and onset age of incident Alzheimer disease dementia","volume":"97","author":"Wilson","year":"2021","journal-title":"Neurology"},{"key":"10.3233\/JAD-220211_ref14","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12544"},{"key":"10.3233\/JAD-220211_ref15","unstructured":"Gupta S (2022) Keep Sharp: Build a Better Brain at Any Age, Simon & Schuster, New York."},{"key":"10.3233\/JAD-220211_ref16","unstructured":"Whitehouse PJ (2008) The Myth of Alzheimer\u2019s, St. Martin\u2019s Griffin, New York."},{"key":"10.3233\/JAD-220211_ref17","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3233\/JAD-210331","article-title":"Effect of a multidomain lifestyle intervention on estimated dementia risk","volume":"82","author":"Solomon","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref18","first-page":"146","article-title":"\u00dcber eine eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allgemeine Z Psychiatrie"},{"key":"10.3233\/JAD-220211_ref19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1192\/bjp.114.512.797","article-title":"The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects","volume":"114","author":"Blessed","year":"1968","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-220211_ref20","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/nen.0b013e31815c5efb","article-title":"Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: Neuritic plaques and neurofibrillary tangles \u201cdo count\u201d when staging disease severity","volume":"66","author":"Nelson","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-220211_ref21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-220211_ref22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2217\/1745509X.4.4.399","article-title":"Screening for memory disorder, dementia, and Alzheimer\u2019s disease","volume":"4","author":"Ashford","year":"2008","journal-title":"Aging Health"},{"key":"10.3233\/JAD-220211_ref23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.gerinurse.2017.11.001","article-title":"Instruments for detection and screening of cognitive impairment for older adults in primary care settings: A review","volume":"39","author":"Scott","year":"2018","journal-title":"Geriatr Nurs"},{"key":"10.3233\/JAD-220211_ref24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/ggi.14360","article-title":"Simple screening models for cognitive impairment in community settings: The IRIDE Cohort Study","volume":"22","author":"Abe","year":"2022","journal-title":"Geriatr Gerontol Int"},{"key":"10.3233\/JAD-220211_ref25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/agm2.12069","article-title":"Advances in screening instruments for Alzheimer\u2019s disease","volume":"2","author":"Zhou","year":"2019","journal-title":"Aging Med (Milton)"},{"key":"10.3233\/JAD-220211_ref26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jalz.2008.07.003","article-title":"Status of computerized cognitive testing in aging: A systematic review","volume":"4","author":"Wild","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220211_ref27","first-page":"267","article-title":"Current state of self-administered brief computerized cognitive assessments for detection of cognitive disorders in older adults: A systematic review","volume":"8","author":"Tsoy","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref28","doi-asserted-by":"crossref","first-page":"e12072","DOI":"10.1002\/trc2.12072","article-title":"Development and validation of language and visuospatial composite scores in ADNI","volume":"6","author":"Choi","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-220211_ref29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/WAD.0b013e318265bcc1","article-title":"Improved statistical power of Alzheimer clinical trials by item-response theory: Proof of concept by application to the activities of daily living scale","volume":"27","author":"Ard","year":"2013","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-220211_ref30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12874-015-0050-x","article-title":"Why item response theory should be used for longitudinal questionnaire data analysis in medical research","volume":"15","author":"Gorter","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"10.3233\/JAD-220211_ref31","doi-asserted-by":"crossref","first-page":"P139","DOI":"10.1093\/geronj\/44.5.P139","article-title":"Alzheimer patient evaluation and the mini-mental state: Item characteristic curve analysis","volume":"44","author":"Ashford","year":"1989","journal-title":"J Gerontol"},{"key":"10.3233\/JAD-220211_ref32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JAD-181198","article-title":"The dichotomy of Alzheimer\u2019s disease pathology: Amyloid-beta and tau","volume":"68","author":"Ashford","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.26167","article-title":"Medicare should not cover aducanumab as a treatment for Alzheimer\u2019s disease","volume":"90","author":"Moghavem","year":"2021","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-220211_ref34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jalz.2007.03.005","article-title":"Should older adults be screened for dementia? It is important to screen for evidence of dementia","volume":"3","author":"Ashford","year":"2007","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220211_ref35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/jgs.13234","article-title":"Findings from the National Memory Screening Day program","volume":"63","author":"Bayley","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-220211_ref36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11920-001-0067-1","article-title":"Modeling the time-course of Alzheimer dementia","volume":"3","author":"Ashford","year":"2001","journal-title":"Curr Psychiatry Rep"},{"key":"10.3233\/JAD-220211_ref37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-220211_ref38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-220211_ref39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/JAD-215394","article-title":"Evaluation of the accuracy of cognitive screening tests in detecting dementia associated with Alzheimer\u2019s disease: A hierarchical Bayesian latent class meta-analysis","volume":"87","author":"Wang","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref40","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1046\/j.1532-5415.2003.51465.x","article-title":"The Mini-Cog as a screen for dementia: Validation in a population-based sample","volume":"51","author":"Borson","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-220211_ref41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3233\/JAD-2003-5506","article-title":"Designing a Brief Alzheimer Screen (BAS)","volume":"5","author":"Mendiondo","year":"2003","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref42","first-page":"1","article-title":"A brief Alzheimer\u2019s screen for clinical practice","volume":"11","author":"Schmitt","year":"2006","journal-title":"Res Pract Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JAD-140774","article-title":"The Montreal Cognitive Assessment in cognitively-intact elderly: A case for age-adjusted cutoffs","volume":"43","author":"Oren","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref44","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1212\/WNL.0b013e318230208a","article-title":"Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample","volume":"77","author":"Rossetti","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-220211_ref45","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jclinepi.2007.11.011","article-title":"Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline","volume":"61","author":"Crane","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.3233\/JAD-220211_ref46","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1212\/WNL.43.8.1559","article-title":"Repeated exposure to the Mini-Mental State Examination and the Information-Memory-Concentration Test results in a practice effect in Alzheimer\u2019s disease","volume":"43","author":"Galasko","year":"1993","journal-title":"Neurology"},{"key":"10.3233\/JAD-220211_ref47","first-page":"269","article-title":"Temporal quantification of Alzheimer\u2019s disease severity: \u2018time index\u2019 model","volume":"6","author":"Ashford","year":"1995","journal-title":"Dementia"},{"key":"10.3233\/JAD-220211_ref48","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13195-021-00838-z","article-title":"Aducanumab produced a clinically meaningful benefit in association with amyloid lowering","volume":"13","author":"Cummings","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-220211_ref49","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jamaneurol.2021.3126","article-title":"US Food and Drug Administration approval of aducanumab-is amyloid load a valid surrogate end point for Alzheimer disease clinical trials?","volume":"78","author":"Planche","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220211_ref50","first-page":"391","article-title":"Editorial: How will aducanumab approval impact AD research?","volume":"8","author":"Weiner","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref51","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0006-291X(84)91209-9","article-title":"Alzheimer\u2019s disease and Down\u2019s syndrome: Sharing of a unique cerebrovascular amyloid fibril protein","volume":"122","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-220211_ref52","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1056\/NEJM198906013202203","article-title":"Amyloid A4 protein and its precursor in Down\u2019s syndrome and Alzheimer\u2019s disease","volume":"320","author":"Rumble","year":"1989","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-220211_ref53","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jalz.2015.07.490","article-title":"The pattern of amyloid accumulation in the brains of adults with Down syndrome","volume":"12","author":"Annus","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220211_ref54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3233\/JAD-2010-101335","article-title":"Plasma amyloid-beta as a function of age, level of intellectual disability, and presence of dementia in Down syndrome","volume":"23","author":"Head","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1567205012999151021102914","article-title":"Editorial: The Link between Alzheimer\u2019s disease and Down syndrome. A historical perspective","volume":"13","author":"Salehi","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-220211_ref56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1385\/JMN:23:3:157","article-title":"APOE genotype effects on Alzheimer\u2019s disease onset and epidemiology","volume":"23","author":"Ashford","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-220211_ref57","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.neurobiolaging.2003.12.023","article-title":"ApoE genotype accounts for the vast majority of AD risk and AD pathology","volume":"25","author":"Raber","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-220211_ref58","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-220211_ref59","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/alz.12450","article-title":"The costs of developing treatments for Alzheimer\u2019s disease: A retrospective exploration","volume":"18","author":"Cummings","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220211_ref60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3233\/JAD-2002-4303","article-title":"ApoE4: Is it the absence of good or the presence of bad?","volume":"4","author":"Ashford","year":"2002","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref61","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1056\/NEJM198508083130616","article-title":"Alzheimer\u2019s disease: Does neuron plasticity predispose to axonal neurofibrillary degeneration?","volume":"313","author":"Ashford","year":"1985","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-220211_ref62","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jamaneurol.2021.3404","article-title":"What the Aducanumab approval reveals about Alzheimer disease research","volume":"78","author":"Manly","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220211_ref63","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1176\/ajp.138.6.829","article-title":"Physostigmine and its effect on six patients with dementia","volume":"138","author":"Ashford","year":"1981","journal-title":"Am J Psychiatry"},{"issue":"Suppl 3","key":"10.3233\/JAD-220211_ref64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2011-0073","article-title":"Imaging the Alzheimer brain","volume":"26","author":"Ashford","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref65","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/00005072-199810000-00009","article-title":"Neuropil threads are collinear with MAP2 immunostaining in neuronal dendrites of Alzheimer brain","volume":"57","author":"Ashford","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-220211_ref66","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.trci.2019.06.005","article-title":"Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer\u2019s disease clinical trials","volume":"5","author":"Andrews","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-220211_ref67","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.neubiorev.2013.05.008","article-title":"Ascending monoaminergic systems alterations in Alzheimer\u2019s disease. translating basic science into clinical care","volume":"37","author":"Trillo","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-220211_ref68","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jama.2020.0435","article-title":"Screening for cognitive impairment in older adults: US Preventive Services Task Force recommendation statement","volume":"323","author":"Owens","year":"2020","journal-title":"JAMA"},{"key":"10.3233\/JAD-220211_ref69","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jalz.2007.03.004","article-title":"Statistical and pharmacoeconomic issues for Alzheimer\u2019s screening","volume":"3","author":"Ashford","year":"2007","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220211_ref70","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jalz.2012.08.008","article-title":"Improving dementia care: The role of screening and detection of cognitive impairment","volume":"9","author":"Borson","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220211_ref71","first-page":"434","article-title":"Population-based blood screening for preclinical Alzheimer\u2019s disease in a British birth cohort at age 70","volume":"144","author":"Keshavan","year":"2021","journal-title":"Brain"},{"key":"10.3233\/JAD-220211_ref72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1533317514522852","article-title":"Computerized cognitive testing for older adults: A review","volume":"30","author":"Zygouris","year":"2015","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-220211_ref73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1533317508330222","article-title":"Development and evaluation of a computerized test battery for Alzheimer\u2019s disease screening in community-based settings","volume":"24","author":"Inoue","year":"2009","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-220211_ref74","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.dadm.2015.10.005","article-title":"Five-year biomarker progression variability for Alzheimer\u2019s disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?","volume":"1","author":"Tarnanas","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-220211_ref75","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41746-021-00470-z","article-title":"Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer\u2019s disease: The Altoida large cohort study","volume":"4","author":"Meier","year":"2021","journal-title":"NPJ Digit Med"},{"key":"10.3233\/JAD-220211_ref76","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/tmj.2019.0039","article-title":"Device-embedded cameras for eye tracking-based cognitive assessment: Implications for teleneuropsychology","volume":"26","author":"Bott","year":"2020","journal-title":"Telemed J E Health"},{"key":"10.3233\/JAD-220211_ref77","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3233\/JAD-220015","article-title":"Validity of the web-based, self-directed, neurocognitive performance test in mild cognitive impairment","volume":"86","author":"Doraiswamy","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref78","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3233\/JAD-200666","article-title":"Assessing the attitudes of Greek nurses toward computerized dementia screening","volume":"78","author":"Zygouris","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref79","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-190167","article-title":"A computerized continuous-recognition task for measurement of episodic memory","volume":"69","author":"Ashford","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref80","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3233\/JAD-181003","article-title":"The MemTrax Test compared to the Montreal Cognitive Assessment estimation of mild cognitive impairment","volume":"67","author":"van der Hoek","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref81","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3233\/JAD-200936","article-title":"Validity of the MemTrax Memory Test compared to the Montreal Cognitive Assessment in the detection of mild cognitive impairment and dementia due to Alzheimer\u2019s disease in a Chinese cohort","volume":"80","author":"Liu","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref82","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5498\/wjp.v11.i7.265","article-title":"Cognitive screening for adult psychiatric outpatients: Comparison of the Cognivue\u00ae to the Montreal Cognitive Assessment","volume":"11","author":"Rose","year":"2021","journal-title":"World J Psychiatry"},{"key":"10.3233\/JAD-220211_ref83","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/ADR-200257","article-title":"A virtual reality-based screening test for cognitive impairment in small vessel disease","volume":"5","author":"Limoncu","year":"2021","journal-title":"J Alzheimers Dis Rep"},{"key":"10.3233\/JAD-220211_ref84","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jalz.2018.02.021","article-title":"The Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies","volume":"14","author":"Weiner","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220211_ref85","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/alz.12138","article-title":"Validation of online functional measures in cognitively impaired older adults","volume":"16","author":"Nosheny","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220211_ref86","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-190165","article-title":"Episodic-memory performance in machine learning modeling for predicting cognitive health status classification","volume":"70","author":"Bergeron","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref87","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3233\/JAD-191340","article-title":"Utility of MemTrax and machine learning modeling in classification of mild cognitive impairment","volume":"77","author":"Bergeron","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref88","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/JAD-2012-112003","article-title":"Apathy and depression in mild Alzheimer\u2019s disease: A cross-sectional study using diagnostic criteria","volume":"31","author":"Benoit","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref89","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S1041610218000108","article-title":"Special Issue on mild behavioral impairment and non-cognitive prodromes to dementia","volume":"30","author":"Mortby","year":"2018","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-220211_ref90","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1017\/S1041610217001909","article-title":"Prevalence estimates of mild behavioral impairment in a population-based sample of pre-dementia states and cognitively healthy older adults","volume":"30","author":"Mortby","year":"2018","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-220211_ref91","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3233\/JAD-215133","article-title":"Clinical trajectories of neuropsychiatric symptoms in mild-moderate to advanced dementia","volume":"86","author":"Castillo-Garcia","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220211_ref92","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12557"},{"key":"10.3233\/JAD-220211_ref93","first-page":"1","article-title":"The influence of COVID on cognition and behavior in older adults","volume":"5","author":"Aquadro","year":"2021","journal-title":"J Mental Health Aging"},{"key":"10.3233\/JAD-220211_ref94","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S1041610292000905","article-title":"Assessing Alzheimer severity with a global clinical scale","volume":"4","author":"Ashford","year":"1992","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-220211_ref95","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/156720501205150526115003","article-title":"Functional Activities Questionnaire items that best discriminate and predict progression from clinically normal to mild cognitive impairment","volume":"12","author":"Marshall","year":"2015","journal-title":"Curr Alzheimer Res"},{"issue":"Suppl 2","key":"10.3233\/JAD-220211_ref96","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer\u2019s disease. The Alzheimer\u2019s Disease Cooperative Study","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-220211_ref97","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/01.wnl.0000172958.95282.2a","article-title":"The AD8: A brief informant interview to detect dementia","volume":"65","author":"Galvin","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-220211_ref98","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nrneurol.2014.181","article-title":"Classifying neurocognitive disorders: The DSM-5 approach","volume":"10","author":"Sachdev","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-220211_ref99","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/ADR-170004","article-title":"Use of the Quick Dementia Rating System (QDRS) as an initial screening measure in a longitudinal cohort at risk for Alzheimer\u2019s disease","volume":"1","author":"Berman","year":"2017","journal-title":"J Alzheimers Dis Rep"},{"key":"10.3233\/JAD-220211_ref100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s40120-022-00326-y","article-title":"Staging disease severity using the Alzheimer\u2019s Disease Composite Score (ADCOMS): A retrospective data analysis","volume":"11","author":"Tahami Monfared","year":"2022","journal-title":"Neurol Ther"},{"key":"10.3233\/JAD-220211_ref101","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jalz.2012.09.011","article-title":"Alzheimer\u2019s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting","volume":"9","author":"Cordell","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220211_ref102","doi-asserted-by":"crossref","first-page":"e12255","DOI":"10.1002\/dad2.12255","article-title":"Large-scale sequencing studies expand the known genetic architecture of Alzheimer\u2019s disease","volume":"13","author":"Xue","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-220211_ref103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3233\/JAD-215240","article-title":"A proposed brain-, spine-, and mental- health screening methodology (NEUROSCREEN) for healthcare systems: Position of the Society for Brain Mapping and Therapeutics","volume":"86","author":"Nami","year":"2022","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:05:40Z","timestamp":1777370740000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220211"}},"subtitle":[],"editor":[{"given":"Paula","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":102,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-220211","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]}}}